These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10328588)

  • 1. New chemotherapy options for the treatment of malignant gliomas.
    Burton E; Prados M
    Curr Opin Oncol; 1999 May; 11(3):157-61. PubMed ID: 10328588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targeted therapies and chemotherapy in malignant gliomas.
    Brandsma D; van den Bent MJ
    Curr Opin Oncol; 2007 Nov; 19(6):598-605. PubMed ID: 17906459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances in chemotherapy for malignant gliomas].
    Yoshino A; Katayama Y
    No Shinkei Geka; 2008 Feb; 36(2):173-83. PubMed ID: 18265701
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent developments in the use of chemotherapy in brain tumours.
    van den Bent MJ; Hegi ME; Stupp R
    Eur J Cancer; 2006 Mar; 42(5):582-8. PubMed ID: 16427778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
    Siker ML; Chakravarti A; Mehta MP
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide chemotherapy in recurrent oligodendroglioma.
    van den Bent MJ; Keime-Guibert F; Brandes AA; Taphoorn MJ; Kros JM; Eskens FA; Carpentier AF
    Neurology; 2001 Jul; 57(2):340-2. PubMed ID: 11468326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs in recurrent high grade gliomas.
    Brandes AA; Pasetto LM; Monfardini S
    Anticancer Res; 2000; 20(3B):1913-20. PubMed ID: 10928126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA
    Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract]   [Full Text] [Related]  

  • 9. The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors.
    Friedman HS; Keir ST; Houghton PJ
    Cancer; 2003 May; 97(9 Suppl):2359-62. PubMed ID: 12712457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current chemotherapy for glioblastoma.
    Parney IF; Chang SM
    Cancer J; 2003; 9(3):149-56. PubMed ID: 12952300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in molecular therapies in patients with brain tumors.
    Tremont-Lukats IW; Gilbert MR
    Cancer Control; 2003; 10(2):125-37. PubMed ID: 12712007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
    Kyritsis AP; Levin VA
    Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with irinotecan for the treatment of malignant glioma.
    Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS
    Neuro Oncol; 2009 Feb; 11(1):80-91. PubMed ID: 18784279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of Oligodendrogliomas.
    Drappatz J; Lieberman F
    Prog Neurol Surg; 2018; 31():152-161. PubMed ID: 29393183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cytotoxic drugs as potential treatments for gliomas.
    Drappatz J; Wen PY
    Curr Opin Neurol; 2004 Dec; 17(6):663-73. PubMed ID: 15542974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pattern of care of high-grade gliomas].
    Laigle-Donadey F; Sanson M
    Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel chemotherapeutic agents for the treatment of glioblastoma multiforme.
    Jendrossek V; Belka C; Bamberg M
    Expert Opin Investig Drugs; 2003 Dec; 12(12):1899-924. PubMed ID: 14640936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative chemotherapeutic agents: nitrosoureas, cisplatin, irinotecan.
    Carrillo JA; Munoz CA
    Neurosurg Clin N Am; 2012 Apr; 23(2):297-306, ix. PubMed ID: 22440873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation.
    Nguyen SA; Stechishin OD; Luchman HA; Lun XQ; Senger DL; Robbins SM; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Sep; 20(18):4894-903. PubMed ID: 25078279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.